{
  "docId": "019dd923-5e88-73ef-bd5d-d76a2779de1a",
  "docSlug": "0251578dbff75a2b",
  "documentTitle": "2025 The AI Dossier",
  "authorId": "Deloitte",
  "authorName": "Deloitte",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 138,
  "pageCount": 190,
  "prevPage": 137,
  "nextPage": 139,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide is split into two main sections: 'Managing Risk and Promoting Trust' on the left and 'Potential Benefits' on the right.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "icon_grid"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5d-d76a2779de1a/138",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5d-d76a2779de1a",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5d-d76a2779de1a.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5d-d76a2779de1a#slide-138",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Automated generation and evaluation of compounds can significantly shorten early-stage development timelines—from years to months—enabling rapid responses to emerging diseases and other unmet needs.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-5643-744f-8944-6ffb3962a390",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.42,
        "x": 0.04,
        "y": 0.45
      },
      "kind": "list",
      "text": "Robust and reliable: Early design errors can lead to costly downstream failures. AI outputs should be validated against human benchmarks and continuously monitored. Transparent and explainable: Regulatory approval requires meeting strict standards for safety, efficacy, and traceability. Agent reasoning and decision paths should support explainable outputs, including transparency into the data and assumptions used. Responsible and accountable: Drug discovery is a complex challenge with life-or-death implications. AI agents should be deployed as co-pilots to human scientists, with humans retaining accountability for final go/no-go decisions.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7a5f0490-5957-445a-b9f7-99325069b5f1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.35,
        "x": 0.61,
        "y": 0.29
      },
      "kind": "list",
      "text": "Accelerated time-to-market: Automated generation and evaluation of compounds can significantly shorten early-stage development timelines—from years to months—enabling rapid responses to emerging diseases and other unmet needs. Lower R&D costs: By rapidly identifying and prioritizing candidates that meet key property constraints, AI can reduce development costs and improve the quality of compounds advancing to later stages. Higher likelihood of success: Comprehensive, multi-modal analysis and real-time adaptation improve the chances that selected candidates will advance successfully through clinical trials. The results could include reduce late-stage attrition, improved ROI, and timely delivery of safer, more effective therapies.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a94cb59e-8a00-4eb8-a1e5-95c2e822f187",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.04,
        "y": 0.14
      },
      "kind": "title",
      "text": "End-to-end autonomous drug discovery and development",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2244a562-14b9-47cb-8d81-9dd9fc53f183",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.61,
        "y": 0.24
      },
      "kind": "title",
      "text": "POTENTIAL BENEFITS",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "45b88f3d-7b87-4b5a-b018-a4f0b453763c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.04,
        "y": 0.4
      },
      "kind": "title",
      "text": "MANAGING RISK AND PROMOTING TRUST",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "783e017c-cd22-4b64-9e8d-9469b66f2ee4",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "b978c41a-d2c2-497b-8679-a03935a016ed",
      "evidence": "The slide presents a list of potential benefits related to AI in drug discovery and development.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}